Cargando…

Heterozygous Loss of KRIT1 in Mice Affects Metabolic Functions of the Liver, Promoting Hepatic Oxidative and Glycative Stress

KRIT1 loss-of-function mutations underlie the pathogenesis of Cerebral Cavernous Malformation (CCM), a major vascular disease affecting the central nervous system (CNS). However, KRIT1 is also expressed outside the CNS and modulates key regulators of metabolic and oxy-inflammatory pathways, includin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mastrocola, Raffaella, Aimaretti, Eleonora, Ferreira Alves, Gustavo, Cento, Alessia Sofia, Fornelli, Claudia, Dal Bello, Federica, Ferraris, Chiara, Goitre, Luca, Perrelli, Andrea, Retta, Saverio Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570113/ https://www.ncbi.nlm.nih.gov/pubmed/36232456 http://dx.doi.org/10.3390/ijms231911151

Ejemplares similares

KRIT1 Deficiency Promotes Aortic Endothelial Dysfunction
por: Vieceli Dalla Sega, Francesco, et al.
Publicado: (2019)

Data in support of sustained upregulation of adaptive redox homeostasis mechanisms caused by KRIT1 loss-of-function
por: Antognelli, Cinzia, et al.
Publicado: (2017)

KRIT1 Regulates the Homeostasis of Intracellular Reactive Oxygen Species
por: Goitre, Luca, et al.
Publicado: (2010)

KRIT1 Loss-Of-Function Associated with Cerebral Cavernous Malformation Disease Leads to Enhanced S-Glutathionylation of Distinct Structural and Regulatory Proteins
por: Cianfruglia, Laura, et al.
Publicado: (2019)

Identification of the Kelch Family Protein Nd1-L as a Novel Molecular Interactor of KRIT1
por: Guazzi, Paolo, et al.
Publicado: (2012)

Protein kinase Cα regulates the nucleocytoplasmic shuttling of KRIT1
por: De Luca, Elisa, et al.
Publicado: (2021)

KRIT1 loss of function causes a ROS-dependent upregulation of c-Jun
por: Goitre, Luca, et al.
Publicado: (2014)

KRIT1 loss-of-function induces a chronic Nrf2-mediated adaptive homeostasis that sensitizes cells to oxidative stress: Implication for Cerebral Cavernous Malformation disease
por: Antognelli, Cinzia, et al.
Publicado: (2018)

miR-21 coordinates tumor growth and modulates KRIT1 levels
por: Orso, Francesca, et al.
Publicado: (2013)

Up-regulation of NADPH oxidase-mediated redox signaling contributes to the loss of barrier function in KRIT1 deficient endothelium
por: Goitre, Luca, et al.
Publicado: (2017)

Biological Activities, Health Benefits, and Therapeutic Properties of Avenanthramides: From Skin Protection to Prevention and Treatment of Cerebrovascular Diseases
por: Perrelli, Andrea, et al.
Publicado: (2018)

Effects of Exogenous Dietary Advanced Glycation End Products on the Cross-Talk Mechanisms Linking Microbiota to Metabolic Inflammation
por: Mastrocola, Raffaella, et al.
Publicado: (2020)

Yeast-Derived Recombinant Avenanthramides Inhibit Proliferation, Migration and Epithelial Mesenchymal Transition of Colon Cancer Cells
por: Finetti, Federica, et al.
Publicado: (2018)

Case Report: A novel heterozygous nonsense mutation in KRIT1 cause hereditary cerebral cavernous malformation
por: Liu, Zhenxing, et al.
Publicado: (2023)

Multidrug-Loaded Lipid Nanoemulsions for the Combinatorial Treatment of Cerebral Cavernous Malformation Disease
por: Perrelli, Andrea, et al.
Publicado: (2023)

Dietary Sugars and Endogenous Formation of Advanced Glycation Endproducts: Emerging Mechanisms of Disease
por: Aragno, Manuela, et al.
Publicado: (2017)

The Interplay between ROS and Ras GTPases: Physiological and Pathological Implications
por: Ferro, Elisa, et al.
Publicado: (2012)

Identification of galectin-3 as a novel potential prognostic/predictive biomarker and therapeutic target for cerebral cavernous malformation disease
por: Kar, Souvik, et al.
Publicado: (2023)

Beyond multiple mechanisms and a unique drug: Defective autophagy as pivotal player in cerebral cavernous malformation pathogenesis and implications for targeted therapies
por: Marchi, Saverio, et al.
Publicado: (2016)

Molecular Crosstalk between Integrins and Cadherins: Do Reactive Oxygen Species Set the Talk?
por: Goitre, Luca, et al.
Publicado: (2012)

KRIT1 mutations in three Japanese pedigrees with hereditary cavernous malformation
por: Hirota, Kengo, et al.
Publicado: (2016)

Correction: KRIT1 Regulates the Homeostasis of Intracellular Reactive Oxygen Species
Publicado: (2019)

VEGF signalling enhances lesion burden in KRIT1 deficient mice
por: DiStefano, Peter V., et al.
Publicado: (2019)

Baricitinib counteracts metaflammation, thus protecting against diet-induced metabolic abnormalities in mice
por: Collotta, Debora, et al.
Publicado: (2020)

Dicarbonyl Stress and S-Glutathionylation in Cerebrovascular Diseases: A Focus on Cerebral Cavernous Malformations
por: Antognelli, Cinzia, et al.
Publicado: (2020)

Vitamin D Deficiency and the Risk of Cerebrovascular Disease
por: Kim, Hyun Ah, et al.
Publicado: (2020)

Pharmacological Inhibition of FAK-Pyk2 Pathway Protects Against Organ Damage and Prolongs the Survival of Septic Mice
por: Alves, Gustavo Ferreira, et al.
Publicado: (2022)

Contribution of protein–protein interactions to the endothelial-barrier-stabilizing function of KRIT1
por: Swamy, Harsha, et al.
Publicado: (2022)

Distant Recurrence of a Cerebral Cavernous Malformation in the Vicinity of a Developmental Venous Anomaly: Case Report of Local Oxy-Inflammatory Events
por: Bianconi, Andrea, et al.
Publicado: (2022)

Ticagrelor Conditioning Effects Are Not Additive to Cardioprotection Induced by Direct NLRP3 Inflammasome Inhibition: Role of RISK, NLRP3, and Redox Cascades
por: Penna, Claudia, et al.
Publicado: (2020)

Next-Generation Sequencing Advances the Genetic Diagnosis of Cerebral Cavernous Malformation (CCM)
por: Benedetti, Valerio, et al.
Publicado: (2022)

Unexpected Distribution of KRIT1 Inside the Nucleus: New Insight in a Complex Molecular Pathway
por: Marzo, S., et al.
Publicado: (2014)

Reduced Susceptibility to Sugar-Induced Metabolic Derangements and Impairments of Myocardial Redox Signaling in Mice Chronically Fed with D-Tagatose when Compared to Fructose
por: Collotta, Debora, et al.
Publicado: (2018)

Multifunctional Platinum@BSA–Rapamycin Nanocarriers for the Combinatorial Therapy of Cerebral Cavernous Malformation
por: De Luca, Elisa, et al.
Publicado: (2018)

KRIT-1/CCM1 is a Rap1 effector that regulates endothelial cell–cell junctions
por: Glading, Angela, et al.
Publicado: (2007)

KRIT1 Gene in Patients with Cerebral Cavernous Malformations: Clinical Features and Molecular Characterization of Novel Variants
por: Ricci, Claudia, et al.
Publicado: (2021)

Novel KRIT1/CCM1 mutation in a patient with retinal cavernous hemangioma and cerebral cavernous malformation
por: Reddy, Shantan, et al.
Publicado: (2010)

Inhibition of the HEG1–KRIT1 interaction increases KLF4 and KLF2 expression in endothelial cells
por: Lopez‐Ramirez, Miguel Alejandro, et al.
Publicado: (2021)

Accumulation of Advanced Glycation End-Products and Activation of the SCAP/SREBP Lipogenetic Pathway Occur in Diet-Induced Obese Mouse Skeletal Muscle
por: Mastrocola, Raffaella, et al.
Publicado: (2015)

Variable expression of cerebral cavernous malformations in carriers of a premature termination codon in exon 17 of the Krit1 gene
por: Lucas, Miguel, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_nd895e8665fvkhke7s44ugo3of